Lv12
20 积分 2023-11-09 加入
[Guidelines for the diagnosis and management of multiple myeloma in China (2024 revision)]
1小时前
已完结
[China lymphoma diagnosis and treatment guideline (2026 edition)]
1小时前
已完结
Prognostic Value of Multicolor-Flow Cytometric Measurable Residual Disease Detection in Acute Myeloid Leukemia Prior to Allogeneic Hematopoietic Cell Transplantation: Potential Role of HLA-DR
4个月前
已关闭
Measurable residual disease-guided interventions in patients with acute myeloid leukaemia undergoing allogeneic haematopoietic cell transplantation: best practice recommendations from the European Society for Blood and Marrow Transplantation Practice Harmonisation and Guidelines Committee
4个月前
已完结
Bortezomib plus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 Trial
4个月前
已关闭
The role of allogeneic stem cell transplantation in acute myeloid leukemia. Who, when and what type of conditioning?
4个月前
已完结
Management of ALL in adults: 2024 ELN recommendations from a European expert panel
4个月前
已完结
Safety and Anti-Leukemic Activity of CD123-CAR T Cells in Pediatric Patients with AML: Preliminary Results from a Phase 1 Trial
5个月前
已关闭
皖公网安备34019202002308
